Table 2.

Studies Included in the Review of Nontherapeutic Male Circumcision

StudyLocationOutcomes AnalyzedStudy GroupsNo. of Patients RandomizedAge at Circumcision
EMLA = EMLA Cream, a proprietary cream of 2.5% lidocaine and 2.5% prilocaine; HIV/AIDS = human immunodeficiency virus/acquired immune deficiency syndrome.
a Mattson 2008 reported further outcomes for the Bailey 2007 cohort.
b Kigozi 2008 reported further outcomes for the Gray 2007 cohort.
c Kigozi 2008a reported further outcomes for the Gray 2007 cohort.
Adult circumcision
Auvert et al,13 2005South AfricaHIV/AIDS incidence, adverse events associated with circumcisionImmediate circumcision1,546Median 21 y
Delayed circumcision1,582Median 21 y
Bailey et al,14 2007KenyaHIV/AIDS incidence, adverse events associated with circumcisionImmediate circumcision1,391Median 20 y
Delayed circumcision1,393Median 20 y
Mattson et al,15 2008aKenyaUnique data on sexual risk behavior onlyImmediate circumcision1,391Median 20 y
Delayed circumcision1,393Median 20 y
Gray et al,16 2007UgandaHIV/AIDS incidence, adverse events associated with circumcisionImmediate circumcision2,474Range 15–49 y
Delayed circumcision2,522Range 15–49 y
Kigozi et al,17 2008bUgandaUnique data on sexual satisfaction and function onlyImmediate circumcision2,474Range 15–49 y
Delayed circumcision2,522Range 15–49 y
Kigozi et al,18 2008acUgandaUnique data on safety outcomes onlyImmediate circumcision2,474Range 15–49 y
Delayed circumcision2,522Range 15–49 y
Neonatal circumcision
Macke,19 2001USAPain distress, mother-infant bondingCircumcised with acetaminophen29Mean 29.57±9.18 h
Circumcised with placebo31Mean 26.82±6.37 h
Taddio et al,8 1997CanadaSubsequent pain response during vaccinationUncircumcised32Mean 133±12.9 d
Circumcised with EMLA20Mean 140±23.7 d
Circumcised with placebo26Mean 143±29.4 d